Analysis: Actos controls blood sugar, fat better than Avandia

09/20/2007 | Yahoo!

Takeda Pharmaceutical's diabetes drug Actos outperformed GlaxoSmithKline's Avandia in controlling blood sugar and lipid levels without increasing heart attack risks, researchers report. Actos also proved more effective in lowering LDL cholesterol levels and improving HDL cholesterol levels in an analysis of clinical trial data.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA